Riskpilot← Back to searchSign inGet full accessABBVIE A/S
A/SActiveCVR 34462828Titangade 11Wholesale of pharmaceutical and medical goods · NACE 4646Est. 201259 employees
Revenue 2024
DKK 336,9M
+17% vs 2023
EBITDA margin
5.1%
+2% vs 2023
Equity ratio
35.4%
Financial strength
Net profit 2024
DKK 11,1M
-20% vs 2023
| Revenue | DKK 336,9M | +17% |
| EBITDA | DKK 17,2M | +2% |
| Net profit | DKK 11,1M | -20% |
| Total assets | DKK 206M | +36% |
| Equity | DKK 73M | +18% |
| Employees | 59 | — |
Legal name
ABBVIE A/S
CVR number
34462828
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
14. marts 2012
Share capital
DKK 501.000
Employees
59 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør, et medlem af bestyrelsen eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive handel med farmaceutiske produkter, hospitalsprodukter og diagnostik samt udvikle, producere og markedsføre teknologi og know-how i forbindelse hermed. Selskabet kan derudover yde tjenesteydelser og assistance, herunder af administrativ, driftmæssig, finansiel, forretningsmæssig, videnskabelig eller industriel karakter, i tilknytning til selskabets formål til tredjemænd, aktionærer, datterselskaber eller tilknyttede selkaber.
Address
Titangade 11
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 525.506 | 535.802 | 568.235 | 541.398 | 553.889 | 452.915 | 136.658 | 183.934 | 292.407 | 285.037 | 288.128 | 336.907 |
| Staff expenses | -76.041 | -92.921 | -99.640 | -85.733 | -93.478 | -88.212 | -83.236 | -50.289 | -60.508 | -66.296 | -60.317 | -57.903 |
| EBITDA | 17.809 | 21.259 | 32.178 | 37.471 | 30.205 | 35.386 | 7.554 | 9.861 | 14.531 | 15.400 | 16.877 | 17.221 |
| Depreciation & amort. | -2.306 | -1.635 | -2.032 | -2.080 | -2.069 | -2.190 | -783 | -426 | -233 | -359 | -331 | -375 |
| EBIT | 15.502 | 19.624 | 30.147 | 35.391 | 28.136 | 33.196 | 6.772 | 9.435 | 14.298 | 15.040 | 16.546 | 16.846 |
| Net financials | -172 | -279 | -163 | -93 | 18 | -15 | -94 | -226 | 297 | 751 | 2.981 | -1.105 |
| Profit before tax | 15.330 | 19.345 | 29.984 | 35.298 | 28.154 | 33.182 | 6.677 | 9.209 | 14.596 | 15.791 | 19.528 | 15.741 |
| Tax | 4.740 | 6.225 | 8.461 | 9.043 | 7.252 | 8.093 | 1.867 | 2.253 | 3.401 | 3.585 | 5.793 | 4.685 |
| Net profit | 10.591 | 13.120 | 21.523 | 26.255 | 20.902 | 25.088 | 4.811 | 6.957 | 11.194 | 12.206 | 13.735 | 11.056 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 226.028 | 210.545 | 171.116 | 211.018 | 210.475 | 200.679 | 220.545 | 191.300 | 237.433 | 223.516 | 151.288 | 206.043 |
| Equity | 57.990 | 71.110 | 92.633 | 118.888 | 119.791 | 144.879 | 149.690 | 156.646 | 183.992 | 196.198 | 61.932 | 72.988 |
| Long-term debt | 7.660 | 0 | 0 | 0 | 0 | 0 | 1.441 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 168.037 | 139.435 | 78.483 | 92.129 | 90.684 | 55.800 | 69.414 | 34.653 | 53.442 | 27.318 | 89.355 | 133.055 |
| Total debt | 168.037 | 139.435 | 78.483 | 92.129 | 90.684 | 55.800 | 70.855 | 34.653 | 53.442 | 27.318 | 89.355 | 133.055 |
EBITDA margin
5.1%
This company
15.8%
Market median
-68% vs market
20132024
Equity ratio
35.4%
This company
38.2%
Market median
+7% vs market
20132024
Return on equity
15.1%
This company
18.4%
Market median
+18% vs market
20132024
Net profit margin
3.3%
This company
8.1%
Market median
-59% vs market
20132024
Asset turnover
1.64×
This company
1.12×
Market median
+46% vs market
20132024
Debt / equity
1.82×
This company
0.62×
Market median
-194% vs market
20132024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TL Management | Management | 2019 | — | — |
CD Management | Management | 2012 | — | — |
| Founder | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2013 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2019 | — | — | |
| Chairman | 2012 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2021 | |
| Individual | 100.0% | 100.0% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ABBVIE A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thea Larsen | Management | 0 companies |
| Christina Dyreborg Jeppesen | Management | 0 companies |
| WCA PHARMACEUTICALS INVESTMENTS S.à.r.l. | Founder | 0 companies |
| William Joseph Chase | Chairman | 0 companies |
| Arnaud Jean Jacques Coint-Bavarot | Board of Directors | 0 companies |
| Robert Andrew Michael | Chairman | 0 companies |
| Thomas Craig Freyman | Chairman | 0 companies |
| Linn Kristina Mandahl | Chairman | 0 companies |
| Tom Schjødt | Board of Directors | 0 companies |
| Jens Lange | Board of Directors | 0 companies |
| Shitra Irari Amozurrutia Blancas | Board of Directors | 0 companies |
| Emilie Claudine Demare | Board of Directors | 0 companies |
| Matthew Robert Iles | Chairman | 0 companies |